This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Do 'Bionic Woman' Stocks Have the Right Parts?

Editor's note: This column was submitted by Stockpickr member Susanne Owen, also known as the Trading Nymph.

NBC's reconstructed Bionic Woman series is proving successful, but what about the companies whose technologies really could rebuild a Jaime Sommers into a bionic phenom?

It's been about a month since Jim Cramer featured his bionic picks on "Mad Money." So after recent earnings reports, buyouts news and DOJ settlements, the question arises: Have these proven good, constructive picks for building a powerful portfolio -- especially in light of the fact that the S&P 500 has fallen about 7.8% since then?

The Oct. 10 "Mad Money", starring the "always dashing" Jim Cramer, featured Stryker (SYK - Get Report) and Smith & Nephew (SNN), two orthopedic products makers that build the replacement parts needed to fix faulty joints like hips and knees. Cramer also featured Alcon (ACL), which makes surgical equipment and devices as well as consumer eye-care products to treat eye diseases and disorders.

On his Oct. 12 "Mad Money" show, Cramer featured Tutogen Medical (TTG) as a speculative play. The company uses a process of tissue preservation to deliver sterile bio-implants that are used to repair various bone and other tissue defects in dental, spinal, urology, ophthalmology, head, neck and general surgery procedures. And finally, on his Oct. 16 show, Cramer featured Sonic Innovations (SNCI), which makes small, powerful hearing aids, as another speculative play.

A couple of these bionic plays have since had to fight the Department of Justice. On Sept. 27 Smith & Nephew signed an agreement with the DOJ to defer prosecution. At issue was whether Smith & Nephew (along with Zimmer (ZMH), Stryker (SYK - Get Report), Biomet and Johnson & Johnson (JNJ) subsidiary DePuy Orthopaedics) gave kickbacks to doctors for choosing their products.
1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
SNN $33.35 -2.20%
SYK $109.76 1.10%
ZMH $0.00 0.00%
AAPL $92.92 -0.75%
FB $117.93 -0.11%


Chart of I:DJI
DOW 17,633.11 -18.15 -0.10%
S&P 500 2,048.42 -2.70 -0.13%
NASDAQ 4,717.2630 -8.3760 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs